142 related articles for article (PubMed ID: 9009642)
1. Fluconazole in the prophylaxis of fungal infection after bone marrow transplantation.
Ehninger G; Schuler HK; Sarnow E
Mycoses; 1996; 39(7-8):259-63. PubMed ID: 9009642
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
[TBL] [Abstract][Full Text] [Related]
3. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
Wolff SN; Fay J; Stevens D; Herzig RH; Pohlman B; Bolwell B; Lynch J; Ericson S; Freytes CO; LeMaistre F; Collins R; Pineiro L; Greer J; Stein R; Goodman SA; Dummer S
Bone Marrow Transplant; 2000 Apr; 25(8):853-9. PubMed ID: 10808206
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial.
Winston DJ; Pakrasi A; Busuttil RW
Ann Intern Med; 1999 Nov; 131(10):729-37. PubMed ID: 10577295
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of different prophylactic antifungal regimens in bone marrow transplantation.
Annaloro C; Oriana A; Tagliaferri E; Bertolli V; Della Volpe A; Soligo D; Ibatici A; Pozzoli E; Lambertenghi Deliliers GL
Haematologica; 1995; 80(6):512-7. PubMed ID: 8647515
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients.
Winston DJ; Busuttil RW
Transplantation; 2002 Sep; 74(5):688-95. PubMed ID: 12352887
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of yeast colonization and infections in paediatric bone marrow transplant recipients.
Hoppe JE; Klausner M; Klingebiel T; Niethammer D
Mycoses; 1997; 40(1-2):47-54. PubMed ID: 9260481
[TBL] [Abstract][Full Text] [Related]
8. The Role of Fluconazole Prophylaxis Regimen and the Regimes Chosen by the Patient’s Risk of Fungal Infection in Reducing the Infection Rate after Bone Marrow Transplantation.
Pourghasemian M; Mehdizadeh M; Hajfathali A; Habibzadeh A; Hosseini MH
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1543-1546. PubMed ID: 29936729
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group.
Philpott-Howard JN; Wade JJ; Mufti GJ; Brammer KW; Ehninger G
J Antimicrob Chemother; 1993 Jun; 31(6):973-84. PubMed ID: 8360134
[TBL] [Abstract][Full Text] [Related]
10. Antifungal prophylaxis in bone marrow transplant.
Lam HH; Althaus BL
Ann Pharmacother; 1995 Sep; 29(9):921-4. PubMed ID: 8547742
[TBL] [Abstract][Full Text] [Related]
11. Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy.
MacMillan ML; Goodman JL; DeFor TE; Weisdorf DJ
Am J Med; 2002 Apr; 112(5):369-79. PubMed ID: 11904111
[TBL] [Abstract][Full Text] [Related]
12. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
Winston DJ; Maziarz RT; Chandrasekar PH; Lazarus HM; Goldman M; Blumer JL; Leitz GJ; Territo MC
Ann Intern Med; 2003 May; 138(9):705-13. PubMed ID: 12729424
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant.
Hiemenz J; Cagnoni P; Simpson D; Devine S; Chao N; Keirns J; Lau W; Facklam D; Buell D
Antimicrob Agents Chemother; 2005 Apr; 49(4):1331-6. PubMed ID: 15793107
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.
Kanda Y; Yamamoto R; Chizuka A; Hamaki T; Suguro M; Arai C; Matsuyama T; Takezako N; Miwa A; Kern W; Kami M; Akiyama H; Hirai H; Togawa A
Cancer; 2000 Oct; 89(7):1611-25. PubMed ID: 11013378
[TBL] [Abstract][Full Text] [Related]
15. Fluconazole versus oral polyenes in the prophylaxis of immunocompromised patients: a cost-minimization analysis.
Wakerly L; Craig AM; Malek M; Hoffmeyer U; Lloyd A; Valette F; Phillips R; Zabihollah M
J Hosp Infect; 1996 May; 33(1):35-48. PubMed ID: 8738200
[TBL] [Abstract][Full Text] [Related]
16. Itraconazole oral solution as antifungal prophylaxis in children undergoing stem cell transplantation or intensive chemotherapy for haematological disorders.
Foot AB; Veys PA; Gibson BE
Bone Marrow Transplant; 1999 Nov; 24(10):1089-93. PubMed ID: 10578159
[TBL] [Abstract][Full Text] [Related]
17. Effect of fluconazole prophylaxis on fever and use of amphotericin in neutropenic cancer patients. Bone Marrow Transplantation Team.
Chandrasekar PH; Gatny CM
Chemotherapy; 1994; 40(2):136-43. PubMed ID: 8131635
[TBL] [Abstract][Full Text] [Related]
18. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
Kern W; Behre G; Rudolf T; Kerkhoff A; Grote-Metke A; Eimermacher H; Kubica U; Wörmann B; Büchner T; Hiddemann W
Cancer; 1998 Jul; 83(2):291-301. PubMed ID: 9669812
[TBL] [Abstract][Full Text] [Related]
19. Antifungal prophylaxis with low-dose fluconazole during bone marrow transplantation. The Bone Marrow Transplantation Team.
Alangaden G; Chandrasekar PH; Bailey E; Khaliq Y
Bone Marrow Transplant; 1994 Dec; 14(6):919-24. PubMed ID: 7711669
[TBL] [Abstract][Full Text] [Related]
20. Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients.
Goa KL; Barradell LB
Drugs; 1995 Oct; 50(4):658-90. PubMed ID: 8536553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
